CME Group Quarterly Cash Flow Statement
NASDAQ: CMEFinanceInvestment Bankers/Brokers/ServiceUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
CME Group free cash flow
In the quarter ended Jun 30, 2026, CME Group generated $947.1 million of operating cash flow and spent $23.6 million on capital expenditures. That left free cash flow of $923.5 million, a free-cash-flow margin of 54.1% of revenue. Free cash flow was down 11.2% from the prior year's $1.04 billion.
CME Group returned $468.1 million to shareholders through dividends, equal to 51% of free cash flow. Free cash flow covered dividend payments 2.0 times.
Summary generated from market data by MetaCap's automated system. Methodology
CME Group cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.04B | 1.15B | 1.18B | 908.00M | 1.03B | 956.20M | 874.60M | 912.80M | 883.20M | 855.20M | 814.60M | 750.20M |
| Net Income growth (YoY) | +1.63% | +20.72% | +35.25% | -0.53% | +16.07% | +11.81% | +7.37% | +21.67% | +13.58% | -3.24% | +27.70% | +10.39% |
| Depreciation & Amortization | 28.20M | 27.20M | — | 26.40M | 27.30M | 27.30M | — | 28.20M | 28.70M | 30.10M | — | 31.10M |
| Stock-Based Compensation | 24.80M | 21.80M | 28.90M | 24.00M | 20.70M | 21.20M | 27.10M | 20.30M | 18.80M | 23.30M | 24.30M | 18.90M |
| Change in Working Capital | 151.10M | -296.30M | -58.80M | 61.20M | 100.50M | -162.80M | 4.70M | 17.30M | 22.80M | -74.90M | 95.30M | 35.40M |
| Operating Cash Flow | 947.10M | 1.26B | 1.13B | 968.10M | 1.06B | 1.12B | 1.02B | 1.00B | 776.90M | 892.70M | 1.04B | 856.70M |
| Capital Expenditures | -23.60M | -21.80M | -32.50M | -18.40M | -18.40M | -14.20M | -26.20M | -29.80M | -18.20M | -19.80M | -20.80M | -19.90M |
| Investing Cash Flow | -29.40M | -23.00M | 1.55B | -19.10M | -18.00M | -16.00M | -25.30M | -29.50M | -5.00M | -22.80M | -20.40M | -19.50M |
| Dividends Paid | -468.10M | -2.70B | -455.00M | -455.30M | -455.30M | -2.57B | -418.80M | -418.50M | -418.50M | -2.33B | -400.10M | -400.00M |
| Debt Issued | 0 | 0 | 0 | -1.70M | 0 | 742.30M | 0 | 0 | 0 | 0 | 0 | 0 |
| Debt Repaid | 0 | 0 | — | 0 | 0 | -750.00M | — | 0 | 0 | 0 | — | 0 |
| Financing Cash Flow | -8.09B | 2.12B | 9.90B | 6.40B | 21.00B | 19.21B | -984.10M | 13.35B | -9.22B | 1.94B | 2.59B | -26.47B |
| Net Change in Cash | -7.17B | 3.35B | 12.59B | 7.35B | 22.04B | 20.31B | 8.50M | 14.32B | -8.45B | 2.81B | 3.61B | -25.63B |
| Free Cash Flow | 923.50M | 1.24B | 1.10B | 949.70M | 1.04B | 1.10B | 991.70M | 973.20M | 758.70M | 872.90M | 1.02B | 836.80M |
This table shows 12 quarterly periods of CME Group's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CME's reporting calendar. What is a cash flow statement?